59089-68-8Relevant articles and documents
Aniline analogs as glycogen synthase activators
-
Page/Page column 14, (2011/05/13)
Provided herein are compounds of the formula (I): as well as pharmaceutically acceptable salts thereof, wherein the substituents are as those disclosed in the specification. These compounds, and the pharmaceutical compositions containing them, are useful for the treatment of metabolic diseases and disorders such as, for example, type II diabetes mellitus.
Process for the preparation of 5-(2,4-difluorophenyl)-salicylic acid
-
, (2008/06/13)
A process for the preparation of 5-(2,4-difluorophenyl)-salicylic acid comprising the reaction of an organometallic derivative with a suitable substituted benzene in the presence of a transition-metal based catalyst is described.
Process for the preparation of 5-(2,4-difluorophenyl)-salicylic acid
-
, (2008/06/13)
A process for the preparation of 5-(2,4-difluorophenyl)-salicylic acid comprising the reaction of an organometallic derivative with a suitable substituted benzene in the presence of a transition-metal based catalyst is described.